LSIPR, Gowling WLG team up for biologics survey

Life Sciences IP Review has partnered with international law firm Gowling WLG to launch the Patent Litigation Survey to appraise the patent trends in biologics, biosimilars and next generation therapies.

The survey will help inform an upcoming report, which will be made available to all participants.

Anyone involved in or interested in the fields of biologics, T-cell or gene therapies as either corporate or legal counsel, is invited to take part.

Click here to take the survey.

Did you enjoy reading this story?  Sign up to our free daily newsletters and get stories sent like this straight to your inbox